Guggenheim Maintains Buy on Xponential Fitness, Lowers Price Target to $25
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst John Heinbockel has maintained a Buy rating on Xponential Fitness (NYSE:XPOF) but reduced the price target from $30 to $25.
November 15, 2023 | 7:08 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Guggenheim analyst reaffirms Buy rating on XPOF but lowers price target to $25, indicating a potential upside but with caution.
The maintenance of a Buy rating suggests that Guggenheim's outlook on XPOF remains positive, indicating potential for stock price growth. However, the reduction in the price target could reflect a tempered expectation for the stock's performance or a response to market conditions. This could lead to a neutral short-term impact as investors digest the mixed signals of continued confidence against a lower price target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100